A.K. FEYSKHANOV¹, E.A. GAYSINA¹, D.V. VASEEV²

¹Republican Clinical Hospital of the MH of RT, 138 Orenburgskiy Trakt, Kazan, Russian Federation, 420064

²Kazan State Medical University, 49 Butlerov St., Kazan, Russian Federation, 420012

Feyskhanov A.K. — doctor of the Vascular Surgery Department № 1, tel. (843) 296-06-42, e-mail: faygiz@mail.ru

Gaysina E.A. — doctor of the Vascular Surgery Department №1, tel. +7-905-039-51-74, e-mail: kalbas77@yandex.ru

Vaseev D.V. — student of the medical faculty, tel. +7-960-040-60-98, e-mail: dvaseew@mail.ru

Retrospective analysis of 199 patients with terminal chronic renal failure receiving renal replacement therapy by program hemodialysis in 2015 in one of the dialysis center of Tatarstan Republic was presented. The status evaluation of permanent vascular access at the beginning of hemodialysis, consider the number of central venous catheterization (number of long standing catheters) was performed. Among them — 105 (52.8%) men and 94 (47.2%) women. Average — 53.3 years ± 1 year. Average time on hemodialysis — 56,2 months ± 4,7 months. 67 (33.7%) of the patients started hemodialysis with native vascular access (arterio-venous fistula), only 1 (0.5%) patient had permanent access using PTFE-graft, and 131 (65.8%) patients had a permanent catheter installed. The ratio of the proximal and distal native AVF was 1:33, respectively.

Key words: arteriovenous fistula, permanent catheter, chronic renal failure, program hemodialysis.

REFERENCES

1. Bikbov B.T., Tomilina N.A. Status replacement therapy in patients with chronic renal failure in the Russian Federation in 1998-2009 years. Nefrologiya i dializ, 2011, vol. 13(3), rr. 150-264 (in Russ.).
2. Feldman H.I., Kobrin S., Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol, 1996, vol. 7, rr. 523-535.
3. Dixon B.S., Novak L., Fangman J. Hemodialysis vascular access survival: upper-arm native arteriovenous fistula. Am J Kidney Dis, 2002, vol. 39, rr. 92-101.
4. Pisoni R.L., Young E.W., Dykstra D.M. et al. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int, 2002, Jan, vol. 61(1), rr. 305-16.
5. Hoen B., Kessler M., Hestin D. et al. Risk factors for bacterial infections in chronic haemodialysis adult patients: a multicentre prospective survey. Nephrol Dial Transplant, 1995, vol. 10, rr. 377-381.
6. Combe C., Pisoni R.L., Port F.K. et al. Dialysis Outcomes and Practice Patterns Study: data on the use of central venous catheters in chronic hemodialysis. Néphrologie, 2001, vol. 22, rr. 379-384.
7. Weyde W., Badowski R., Krajewska M. et al. Femoral and iliac vein stenoses after prolonged femoral vein catheter insertion. Nephrol Dial Transplant, 2004, Jun, vol. 19(6), rr. 1618-21.
8. Salgado O.J., Urdaneta B., Colmenares B. et al. Right versus left internal jugular vein catheterization for hemodialysis: complications and impact on ipsilateral access creation. Artif Organs, 2004, Aug, vol. 28(8), rr. 728-33.
9. Mickley V. Central vein obstruction in vascular access. Eur J Vasc Endovasc Surg, 2006, Oct, vol. 32(4), rr. 439-44.
10. Krajíčková D., Peregrin J.H. Intervenční léčba stenóz a uzávěrů centrálního žilního řečiště hemodializovaných nemocných. Čes Radiol, 2001, vol. 55, rr. 149-153.
11. Sasadeusz K.J., Trerotola S.O., Shah H. et al. Tunneled jugular small-bore central catheters as an alternative to peripherally inserted central catheters for intermediate-term venous access in patients with hemodialysis and chronic renal insufficiency. Radiology, 1999 Oct, vol. 213(1), rr. 303-6.